In recent years, nanoparticles—bionanomaterials with specific physicochemical properties—have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs.

This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research.

Hala Gali-Muhtasib is a tenured professor in the Department of Biology and director of the Center for Drug Discovery, American University of Beirut, Lebanon. She earned her PhD from Kansas State University, USA, and is a prominent scholar with outstanding contributions to the study of the role of natural and novel synthetic compounds in cancer therapy. She has published more than 100 research articles in peer-reviewed journals and is a recipient of five international/regional research awards for her contributions to anticancer drug therapy.

Racha Chouaib is a researcher at the Center for Drug Discovery, American University of Beirut, and assistant professor at the Lebanese International University and the Lebanese University. She received her PhD from the University of Montpellier, France, in 2016. She is a specialist in molecular genetics (RNA field) and has contributed to studies on the role of drug delivery systems in cancer therapy. She has published several research articles in peer-reviewed journals.